Synthesis and optimization of novel (3S,5R)-5-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)piperidine-3-carboxamides as orally active renin inhibitors

被引：9

作者：

Mori, Yutaka ^{[1
]}

Ogawa, Yasuyuki ^{[2
]}

Mochizuki, Akiyoshi ^{[3
]}

Nakamura, Yuji ^{[3
]}

Fujimoto, Teppei ^{[3
]}

Sugita, Chie ^{[3
]}

Miyazaki, Shojiro ^{[3
]}

Tamaki, Kazuhiko ^{[3
]}

Nagayama, Takahiro ^{[4
]}

Nagai, Yoko ^{[5
]}

Inoue, Shin-ichi ^{[5
]}

Chiba, Katsuyoshi ^{[6
]}

Nishi, Takahide ^{[7
]}

机构：

[1] Daiichi Sankyo Co Ltd, New Modal Res Labs, Shinagawa Ku, Tokyo 1408710, Japan

[2] Daiichi Sankyo Co Ltd, Venture Sci Labs, Shinagawa Ku, Tokyo 1408710, Japan

[3] Daiichi Sankyo Co Ltd, Med Chem Res Labs, Shinagawa Ku, Tokyo 1408710, Japan

[4] Daiichi Sankyo Co Ltd, Cardiovasc Metabol Res Labs, Shinagawa Ku, Tokyo 1408710, Japan

[5] Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, Tokyo 1408710, Japan

[6] Daiichi Sankyo Co Ltd, Med Safety Res Labs, Edogawa Ku, Tokyo 1348630, Japan

[7] Daiichi Sankyo India Pharma Pvt Ltd, Daiichi Sankyo Life Sci Res Ctr India, Gurgaon 122015, Haryana, India

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2013年 / 21卷 / 18期

关键词：

Hypertension; Renin; Piperidine; Ketopiperazine; TRANSGENIC RATS; BLOOD-PRESSURE; DISCOVERY; DESIGN; ALISKIREN; POTENT; MARMOSETS; DS-8108B;

D O I：

10.1016/j.bmc.2013.06.057

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

We report synthesis and optimization of a series of (3S,5R)-5-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)piperidine-3-carboxamides as renin inhibitors. Chemical modification of P-1', P-2' and P-3 portions led to a promising 3,5-disubstituted piperidine 32o showing high renin inhibitory activity and favorable oral exposure in both rats and cynomolgus monkeys with acceptable CYP and hERG current inhibition. Compound 32o exhibited a significant blood pressure lowering effect by oral administration in two hypertensive animal models, double transgenic rats and furosemide pretreated cynomolgus monkeys. (C) 2013 Elsevier Ltd. All rights reserved.

引用

页码：5907 / 5922

页数：16

共 24 条

[1] The discovery and synthesis of potent zwitterionic inhibitors of renin [J].

Aspiotis, Renee ;

Chen, Austin ;

Cauchon, Elizabeth ;

Dube, Daniel ;

Falgueyret, Jean-Pierre ;

Gagne, Sebastien ;

Gallant, Michel ;

Grimm, Erich L. ;

Houle, Robert ;

Juteau, Helene ;

Lacombe, Patrick ;

Laliberte, Sebastien ;

Levesque, Jean-Francois ;

MacDonald, Dwight ;

McKay, Dan ;

Percival, M. David ;

Roy, Patrick ;

Soisson, Stephen M. ;

Wu, Tom .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (08) :2430-2436

[2] Design and Preparation of Potent, Nonpeptidic, Bioavailable Renin Inhibitors [J].

Bezencon, Olivier ;

Bur, Daniel ;

Weller, Thomas ;

Richard-Bildstein, Sylvia ;

Remen, Lubos ;

Sifferlen, Thierry ;

Corminboeuf, Olivier ;

Grisostomi, Corinna ;

Boss, Christoph ;

Prade, Lars ;

Delahaye, Stephane ;

Treiber, Alexander ;

Strickner, Panja ;

Binkert, Christoph ;

Hess, Patrick ;

Steiner, Beat ;

Fischli, Walter .

JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (12) :3689-3702

[3] Reversal of diastereofacial selectivity in hydride reductions of N-tert-butanesulfinyl imines [J].

Colyer, John T. ;

Andersen, Neil G. ;

Tedrow, Jason S. ;

Soukup, Troy S. ;

Faul, Margaret M. .

JOURNAL OF ORGANIC CHEMISTRY, 2006, 71 (18) :6859-6862

[4]

EHARA T, 2007, Patent No. 2007077005

[5] 2-NITROBENZENESULFONAMIDES AND 4-NITROBENZENESULFONAMIDES - EXCEPTIONALLY VERSATILE MEANS FOR PREPARATION OF SECONDARY-AMINES AND PROTECTION OF AMINES [J].

FUKUYAMA, T ;

JOW, CK ;

CHEUNG, M .

TETRAHEDRON LETTERS, 1995, 36 (36) :6373-6374

[6] SPECIES SPECIFICITY OF RENIN KINETICS IN TRANSGENIC RATS HARBORING THE HUMAN RENIN AND ANGIOTENSINOGEN GENES [J].

GANTEN, D ;

WAGNER, J ;

ZEH, K ;

BADER, M ;

MICHEL, JB ;

PAUL, M ;

ZIMMERMANN, F ;

RUF, P ;

HILGENFELDT, U ;

GANTEN, U ;

KALING, M ;

BACHMANN, S ;

FUKAMIZU, A ;

MULLINS, JJ ;

MURAKAMI, K .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7806-7810

[7]

HERSHEY JC, 2005, DRUG DISCOV TODAY, V2, P181

[8] Discovery of VTP-27999, an Alkyl Amine Renin Inhibitor with Potential for Clinical Utility [J].

Jia, Lanqi ;

Simpson, Robert D. ;

Yuan, Jing ;

Xu, Zhenrong ;

Zhao, Wei ;

Cacatian, Salvacion ;

Tice, Colin M. ;

Guo, Joan ;

Ishchenko, Alexey ;

Singh, Suresh B. ;

Wu, Zhongren ;

McKeever, Brian M. ;

Bukhtiyarov, Yuri ;

Johnson, Judith A. ;

Doe, Christopher P. ;

Harrison, Richard K. ;

McGeehan, Gerard M. ;

Dillard, Lawrence W. ;

Baldwin, John J. ;

Claremon, David A. .

ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (10) :747-751

[9]

Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3

[10] Rational design, synthesis, and structure-activity relationships of aryltriazoles as novel corticotropin-releasing factor-1 receptor antagonists [J].

Lowe, RF ;

Nelson, J ;

Dang, TN ;

Crowe, PD ;

Pahuja, A ;

McCarthy, JR ;

Grigoriadis, DE ;

Conlon, P ;

Saunders, J ;

Chen, C ;

Szabo, T ;

Chen, TK ;

Bozigian, H .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (05) :1540-1549

← 1 2 3 →